Race Oncology Ltd is moving in the right direction: Pitt Street Research

Race Oncology Ltd (ASX:RAC) has retained its valuation of A$3.4 billion base case and A$6.1 billion bull case from Pitt Street Research as it continues to...

Related Keywords

Australia ,Australian ,Damian Clarke Bruce ,Race Oncology Ltd ,Pitt Street Research ,Pitt Street ,Investigational New Drug ,Australian Phase ,Managing Director ,